Recombinant Influenza A Virus H3N2 Neuraminidase Protein, CF

R&D Systems | Catalog # 6875-NM

R&D Systems
100% Guarantee

Key Product Details

  • R&D Systems Sf 21 (baculovirus)-derived Recombinant Influenza A Virus H3N2 Neuraminidase Protein (6875-NM)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

Sf 21 (baculovirus)

Accession Number

Q91MA2

Applications

Enzyme Activity
View all Viral Neuraminidase Proteins and Enzymes »

Product Specifications

Source

Spodoptera frugiperda, Sf 21 (baculovirus)-derived influenza a virus h3n2 Viral Neuraminidase protein
Ala46-Ile469, vasodilator-stimulated phosphoprotein tetramerization domain and a C-terminal 6-His tag

Purity

>85%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Ser (of tetramerization domain)

Predicted Molecular Mass

53 kDa

SDS-PAGE

57-65 kDa, reducing conditions

Activity

Measured by its ability to cleave a fluorogenic substrate, 2’-(4-Methylumbelliferyl)-alpha -D-N-acetylneuraminic acid.
The specific activity is >10,000 pmol/min/μg, as measured under the described conditions.

Formulation, Preparation, and Storage

6875-NM
Formulation Supplied as a 0.2 μm filtered solution in Tris, NaCl, CaCl2, DTT and Glycerol.
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -70 °C as supplied.
  • 3 months, -70 °C under sterile conditions after opening.

Background: Viral Neuraminidase

Neuraminidase (NA) and hemagglutinin (HA) are the two predominant membrane glycoproteins found on the surface of an influenza virus particle. They are essential for the infectious cycle of the virus. HA recognizes and binds to the sialic acid on the host cell membrane to initiate a viral infection. NA cleaves the sialic acid at the end of the cycle, allowing the progeny virus to leave the host thus initiating the next round of infection (1). In the early stage of an infection, NA may also assist in viral penetration of the mucus layer in the airway of a host. Nine subtypes of NA (N1 to N9) have been identified, all of which are believed to be tetrameric and share a basic structure consisting of a globular head, a thin stalk region, and a small hydrophobic region that anchors the protein in the virus membrane (2). Glycosylation is also found to be important for the stability and activity of these enzymes (3). Due to their critical role in the infectious cycle of a virus, influenza viral neuraminidases are frequently used as targets for drug design. Both the anti-influenza drugs Tamiflu® and Relenza® are neuraminidase inhibitors. According to a recent structure determination (4), neuraminidases from influenza type A viruses form two genetically distinct groups, with the N1 and N2 neuraminidases representing each of the two groups. This recombinant protein is based on the sequences of the virus isolated from 1968 Hong Kong flu pandemic (5). An artificial tetramerization domain from the vasodilator-stimulated phosphoprotein (6) was inserted at the N-terminus to assist in oligomerization of the recombinant protein.

References

  1. Palese, P. & Compans, R. W. (1976) J. Gen. Virol. 33:159.
  2. Colman, P. M. et al. (1983) Nature 303:41.
  3. Wu, Z.L. et al. (2009) Biochem. Biophys. Res. Commun. 379:749.
  4. Russell, R.J. et al. (2006) Nature 443:45.
  5. Shortridge, K.F. et al. (1977) Science 196:1454.
  6. Kuhnel, K. et al. (2004) Proc. Natl. Acad. Sci. U. S. A. 101:17027.

Long Name

Neuraminidase

Alternate Names

NANH

UniProt

Q91MA2

Additional Viral Neuraminidase Products

Product Documents for Recombinant Influenza A Virus H3N2 Neuraminidase Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Influenza A Virus H3N2 Neuraminidase Protein, CF

For research use only

Customer Reviews for Recombinant Influenza A Virus H3N2 Neuraminidase Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Influenza A Virus H3N2 Neuraminidase Protein, CF and earn rewards!

Have you used Recombinant Influenza A Virus H3N2 Neuraminidase Protein, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for Recombinant Influenza A Virus H3N2 Neuraminidase Protein, CF (6875-NM):

Materials
  • Assay Buffer: 25 mM MES, 500 mM NaCl, 5 mM CaCl2, pH 6.5
  • Recombinant Influenza A Virus H3N2 Neuraminidase (rvH3N2) (Catalog # 6875-NM)
  • Substrate: 4-Methylumbelliferyl-alpha -D-N-acetylneuraminic acid (Sigma, Catalog # M8639), 10 mM stock  in DMSO
  • F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
  • Fluorescent Plate Reader (SpectraMax Gemini EM by Molecular Devices) or equivalent
  1. Dilute rvH3N2 Neuraminidase to 0.2 ng/μL in Assay Buffer.
  2. Dilute Substrate to 400 µM in Assay Buffer.
  3. Load 50 µL of the 0.2 ng/μL rvH3N2 Neuraminidase into a black well plate and start the reaction by adding 50 µL of 400 µM Substrate. Include a Substrate Blank containing Assay Buffer in place of rvH3N2 Neuraminidase.
  4. Read at excitation and emission wavelengths of 365 nm and 445 nM (top read), respectively, in kinetic mode for 5 minutes.
  5. Calculate specific activity:

     Specific Activity (pmol/min/µg) =

 Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU)
amount of enzyme (µg)

     *Adjusted for Substrate Blank
     **Derived using calibration standard 4-Methylumbelliferone (Sigma, Catalog # M1381).

Per Well:
  • rvH3N2 Neuraminidase: 0.010 µg
  • Substrate: 200 µM

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes